Skip to main content

ERI3 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84867

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-84867-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the C-terminal region of Human ERI3. Peptide sequence: KAYSFAMGCWPKNGLLDMNKGLSLQHIGRPHSGIDDCKNIANIMKTLAYR The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ERI3 Antibody

Western Blot: ERI3 Antibody [NBP2-84867]

Western Blot: ERI3 Antibody [NBP2-84867]

Western Blot: ERI3 Antibody [NBP2-84867] - WB Suggested Anti-ERI3 Antibody. Titration: 1.0 ug/ml. Positive Control: 721_B Whole CellERI3 is supported by BioGPS gene expression data to be expressed in 721_B

Applications for ERI3 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ERI3

Alternate Names

ERI1 exoribonuclease 3, ERI1 exoribonuclease family member 3, exoribonuclease 3

Gene Symbol

ERI3

Additional ERI3 Products

Product Documents for ERI3 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ERI3 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...